2024
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, Cunquero M, Castro G, Villemeur M, Nüchel J, Bornikoel A, Dam B, Zirmire RK, Kiran R, Carolis C, Andilla J et al..
2024. TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.. Nat Commun. 15(1):3302. DOI:10.1038/s41467-024-47004-1.
2023
Rana I, Kataria S, Tan TLin, Hajam EYousaf, Kashyap DKumar, Saha D, Ajnabi J, Paul S, Jayappa S, Ananthan ASHP, Kumar P, Zaarour RF, Haarshaadri J, Kansagara G, Rizvi A, Zirmire RK, Badarinath K, Khedkar SUday, Chandra Y, Samuel R et al..
2023. Mindin (SPON2) Is Essential for Cutaneous Fibrogenesis in a Mouse Model of Systemic Sclerosis.. J Invest Dermatol. 143(5):699-710.e10. DOI:10.1016/j.jid.2022.10.011.
2022
Zaveri L, Dhawan J.
2022. Inducible expression of Oct-3/4 reveals synergy with Klf4 in targeting Cyclin A2 to enhance proliferation during early reprogramming.. Biochem Biophys Res Commun. 587:29-35. DOI:10.1016/j.bbrc.2021.11.058.
Zaarour RF, Saha D, Dey R, Dutta A, Kumar P, Rana I, Pulianmackal A, Rizvi A, Misra N, Breton L, Jamora C.
2022. The neuropeptide Substance P facilitates the transition from an inflammatory to proliferation phase-associated responses in dermal fibroblasts.. Exp Dermatol. 31(8):1188-1201. DOI:10.1111/exd.14573.
Sobecki M, Chen J, Krzywinska E, Nagarajan S, Fan Z, Nelius E, Rodriguez JMMonné, Seehusen F, Hussein A, Moschini G, Hajam EY, Kiran R, Gotthardt D, Debbache J, Badoual C, Sato T, Isagawa T, Takeda N, Tanchot C, Tartour E et al..
2022. Vaccination-based immunotherapy to target profibrotic cells in liver and lung.. Cell Stem Cell. 29(10):1459-1474.e9. DOI:10.1016/j.stem.2022.08.012.